Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$36.95 - $82.41 $13.6 Million - $30.4 Million
-369,389 Reduced 63.64%
211,050 $9.55 Million
Q1 2022

May 13, 2022

BUY
$55.7 - $145.79 $10.5 Million - $27.5 Million
188,414 Added 48.06%
580,439 $44.2 Million
Q4 2021

Feb 14, 2022

SELL
$135.05 - $182.59 $57.6 Million - $77.9 Million
-426,801 Reduced 52.12%
392,025 $58.4 Million
Q3 2021

Nov 12, 2021

SELL
$145.58 - $192.14 $14.3 Million - $18.9 Million
-98,204 Reduced 10.71%
818,826 $119 Million
Q2 2021

Aug 13, 2021

BUY
$134.22 - $202.37 $10.1 Million - $15.2 Million
75,273 Added 8.94%
917,030 $180 Million
Q1 2021

May 13, 2021

BUY
$140.25 - $196.86 $118 Million - $166 Million
841,757 New
841,757 $152 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.